// App-Quantinova.ai

OC 04.2 : Factors influencing time from initial presentation to start of plasma exchange in patients with acute thrombotic thrombocytopenic purpura in the United Kingdom

Researchers

Presenter

  • T. Bull

Principal Investigators

  • R. McCulloch

  • A. Doyle

  • P. Nicolson

  • R. Shaw

  • Z. Sayar

  • A. Langridge

  • R. Perry

  • D. Tucker

  • M. Scully

Medical Centers

  • West Suffolk NHS Foundation Trust, UK, Bury St Edmunds, England, United Kingdom

  • Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK, Gloucester, England, United Kingdom

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, Birmingham, England, United Kingdom

  • University of Liverpool, Liverpool, UK, Liverpool, England, United Kingdom

  • University College London Hospitals NHS Foundation Trust, London, UK; Whittington Hospital, London, UK, London, England, United Kingdom

  • Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK, Newcastle-Upon-Tyne, England, United Kingdom

  • Birmingham Centre for Observational and Prospective Studies, Birmingham Surgical Trials Consortium, Birmingham, United Kingdom

  • Royal Cornwall Hospitals NHS Trust, Truro, UK, Truro, England, United Kingdom

  • University College London Hospitals NHS Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Blood/haematological Diseases

Disease

  • Thrombotic thrombocytopenic purpura

Biomarkers

  • ZFP36 Ring Finger Protein Like 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved